ArticleOphthalmology and therapy2023

Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.

Ryan Zubricky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.